Insider Buying: InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Director Buys 4,000 Shares of Stock

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU - Get Free Report) Director Ralph F. Boyd, Jr. bought 4,000 shares of the company's stock in a transaction on Thursday, May 23rd. The stock was purchased at an average cost of $7.13 per share, for a total transaction of $28,520.00. Following the completion of the transaction, the director now owns 6,000 shares in the company, valued at $42,780. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

InfuSystem Trading Down 3.4 %

Shares of INFU traded down $0.24 during mid-day trading on Thursday, reaching $6.92. The company had a trading volume of 59,650 shares, compared to its average volume of 45,565. InfuSystem Holdings, Inc. has a twelve month low of $6.25 and a twelve month high of $11.44. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.57. The stock has a market cap of $147.40 million, a PE ratio of -714,000.00 and a beta of 1.30.

Analysts Set New Price Targets

Several research analysts have weighed in on INFU shares. Lake Street Capital raised InfuSystem to a "strong-buy" rating in a research report on Thursday, May 9th. StockNews.com cut InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Monday, May 13th.

Institutional Investors Weigh In On InfuSystem

A number of hedge funds and other institutional investors have recently bought and sold shares of INFU. WINTON GROUP Ltd acquired a new stake in InfuSystem during the 3rd quarter valued at $101,000. Citigroup Inc. increased its stake in shares of InfuSystem by 124.1% in the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier's stock valued at $488,000 after buying an additional 28,038 shares during the period. First Eagle Investment Management LLC increased its stake in shares of InfuSystem by 29.6% in the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier's stock valued at $4,515,000 after buying an additional 107,001 shares during the period. Heartland Advisors Inc. increased its stake in shares of InfuSystem by 17.6% in the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier's stock valued at $4,820,000 after buying an additional 75,000 shares during the period. Finally, Ranger Investment Management L.P. increased its stake in shares of InfuSystem by 4.7% in the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier's stock valued at $7,271,000 after buying an additional 30,835 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.